Alfred Sandrock, EVP CMO Neuro & Neurodegenerat at BIOGEN INC. (BIIB), sold 183 shares at $261.90 ($48K) on 2016-02-25, disclosed to the SEC on 2016-02-26.
Scheduled sale ($48k) by EVP CMO Neuro & Neurodegenerat under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |